Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy

References

• Bao X, Gao M, Xu H, et al. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Dev Ind Pharm 2015;41:1193–203.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu D, Dong X, et al. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Int J Nanomedicine 2015;10:2101–14.
   PubMed Web of Science ®Google Scholar
• Kathe N, Henriksen B, Chauhan H. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev Ind Pharm 2014;40:1565–75.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Vats R, Dalal V, et al. Design, optimization and evaluation of poly-ɛ-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir. Drug Dev Ind Pharm 2015;41:131–40.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang Y, Li D, et al. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine 2014;9:4107–16.
   PubMed Web of Science ®Google Scholar
• Shao Z, Shao J, Tan B, et al. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Int J Nanomedicine 2015;10:1223–33.
   PubMed Web of Science ®Google Scholar
• Wang L, Luo Q, Lin T, et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm 2015;41:1204–12.
   PubMed Web of Science ®Google Scholar
• Chu Y, Li D, Luo YF, et al. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers. Molecules 2014;19:2445–57.
   PubMed Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Rostami M, et al. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm 2015;41:1137–47.
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 2009;61:203–13.
   Web of Science ®Google Scholar
• Hayashi K, Nakamura M, Miki H, et al. Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics 2014;4:834–44.
   PubMed Web of Science ®Google Scholar
• Minarini PR, de Souza AO, Soares EG, et al. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. Drug Dev Ind Pharm 2012;38:259–63.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wu Y, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 2011;32:8281–90.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yang Y, Li L, et al. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer. ACS Appl Mater Interfaces 2015;7:6661–73.
   PubMed Web of Science ®Google Scholar
• Papademetriou I, Tsinas Z, Hsu J, Muro S. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes. J Control Release 2014;188:87–98.
   PubMed Web of Science ®Google Scholar
• Shiao YS, Chiu HH, Wu PH, Huang YF. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl Mater Interfaces 2014;6:21832–41.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Dai DD, Lu CT, et al. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo. Drug Dev Ind Pharm 2012;38:1090–8.
   PubMed Web of Science ®Google Scholar
• Kulhari H, Pooja D, Singh MK, Chauhan AS. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Dev Ind Pharm 2015;41:232–8.
   PubMed Web of Science ®Google Scholar
• Raoofi A, Khazaei M, Ghanbari A. Protective effect of hydroalcoholic extract of tribulus terrestris on cisplatin induced renal tissue damage in male mice. Int J Prev Med 2015;6:11.
   PubMedGoogle Scholar
• Kim KY, Kim SH, Yu SN, et al. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin. Mol Med Rep 2015;12:1898–904.
   PubMed Web of Science ®Google Scholar
• Zheng D, Dai W, Zhang D, et al. In vivo studies on the oridonin-loaded nanostructured lipid carriers. Drug Deliv 2012;19:286–91.
   PubMed Web of Science ®Google Scholar
• Feng L, E LL, Soloveiv MM, et al. Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma. Oncol Lett 2015;9:1827–32.
   PubMed Web of Science ®Google Scholar
• Jin M, Shen X, Zhao C, et al. In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice. Drug Deliv 2013;20:127–33.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Mardani A, Rostami M. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery. Pharm Dev Technol 2015;20:183–96.
   PubMed Web of Science ®Google Scholar
• Huang RF, Wei YJ, Inbaraj BS, Chen BH. Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int J Nanomedicine 2015;10:2823–46.
   PubMed Web of Science ®Google Scholar
• Wachsmann P, Lamprecht A. Ethylcellulose nanoparticles with bimodal size distribution as precursors for the production of very small nanoparticles. Drug Dev Ind Pharm 2015;41:1165–71.
   PubMed Web of Science ®Google Scholar
• Achouri D, Sergent M, Tonetto A, et al. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part II: optimization of formulation variables using experimental design. Drug Dev Ind Pharm 2015;41:493–501.
   PubMed Web of Science ®Google Scholar
• Segura S, Espuelas S, Renedo MJ, Irache JM. Potential of albumin nanoparticles as carriers for interferon gamma. Drug Dev Ind Pharm 2005;31:271–80.
   PubMed Web of Science ®Google Scholar
• Zheng C, Liu X, Zhu J, Zhao Y. Preparation of cationic biodegradable dextran microspheres loaded with BSA and study on the mechanism of protein loading. Drug Dev Ind Pharm 2012;38:653–8.
   PubMed Web of Science ®Google Scholar
• Hwang TL, Aljuffali IA, Lin CF, et al. Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles. Int J Nanomedicine 2015;10:371–85.
   PubMed Web of Science ®Google Scholar
• Kolishetti N, Dhar S, Valencia PM, et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci USA 2010;107:17939–44.
   PubMed Web of Science ®Google Scholar
• Kasongo KW, Shegokar R, Müller RH, Walker RB. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. Drug Dev Ind Pharm 2011;37:396–407.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394–405.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang J, Wang B, et al. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. Drug Dev Ind Pharm 2016;42:737–46.
   PubMed Web of Science ®Google Scholar
• Kawadkar J, Pathak A, Kishore R, Chauhan MK. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm 2013;39:569–78.
   PubMed Web of Science ®Google Scholar
• Azarmi S, Lobenberg R, Roa WH, et al. Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles. Drug Dev Ind Pharm 2008;34:943–7.
   PubMed Web of Science ®Google Scholar
• Khameneh B, Iranshahy M, Ghandadi M, et al. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus. Drug Dev Ind Pharm 2015;41:989–94.
   PubMed Web of Science ®Google Scholar